LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, Software
IndustriesMetabolomics
ManufacturerWaters
Importance of the Topic
Metabolite identification is a cornerstone of drug discovery and development, providing insights into compound stability, safety assessment, interspecies metabolism differences, and clinical support. Rapid and reliable identification of metabolites accelerates lead optimization and reduces late-stage failures.
Study Objectives and Overview
This study demonstrates a high-throughput workflow integrating the Waters Xevo MRT Mass Spectrometer, ACQUITY Premier UPLC System, and MassMetaSite software. The platform was applied to analyze urinary metabolites of methapyrilene in male Wistar rats using a generic 5-minute reversed-phase LC-MS method.
Methodology
- Animal Study: Rats dosed orally with 0, 50, or 150 mg/kg methapyrilene; urine collected pre-dose and 16 h post-dose on days 3 and 5.
- Sample Preparation: Urine diluted in acetonitrile/methanol (90:10), vortexed, chilled, centrifuged, and diluted before LC-MS analysis.
Used Instrumentation
- Chromatography: ACQUITY Premier UPLC with CORTECS C18 1.6 µm, 2.1 × 50 mm column; 5–95% organic gradient over 5 min at 0.6 mL/min.
- Mass Spectrometry: Xevo MRT in positive ESI mode; DIA and DDA acquisition; sub-ppm mass accuracy in MS1 and MS2; desolvation gas 800 mL/min; source at 120 °C; collision energy ramp 5–50 eV.
- Data Software: waters_connect for data acquisition; MassMetaSite for automated metabolite detection, structural assignment, and probability scoring.
Main Results and Discussion
Forty-two methapyrilene-related metabolites were detected, each with mass errors below 1 ppm. Retention times ranged from 0.12 to 1.16 min, with peak widths of approximately 3 s yet yielding over 10 scans per peak. High spectral density enabled precise biotransformation site localization. The platform identified oxidative, dealkylated, dihydroxylated, N-oxide, and O-glucuronide metabolites, including low-abundance species critical for toxicological evaluation. The dual-gain ADC GPU architecture provided a dynamic range exceeding five orders of magnitude, ensuring reliable detection across a broad concentration range.
Practical Benefits and Applications
- High throughput: generic 5-min LC-MS method with minimal compound-specific setup.
- Automated workflow: seamless data transfer and rapid processing (< minutes).
- Enhanced confidence: sub-ppm accuracy in MS1/MS2 supports precise structural assignments.
- Broad utility: applicable to early discovery screening and comprehensive metabolite profiling in development.
Future Trends and Opportunities
Emerging directions include integrating machine learning to refine biotransformation predictions, expanding the approach to other biological matrices, and leveraging real-time data analytics for on-the-fly metabolite identification. Advances in ion mobility and high-field asymmetric waveform ion mobility spectrometry (FAIMS) could further improve selectivity and throughput.
Conclusion
The combined Xevo MRT–ACQUITY Premier UPLC–MassMetaSite platform delivers rapid, accurate, and high-throughput metabolite identification. Sub-1 ppm mass accuracy and wide dynamic range enhance structural confidence across major and trace metabolites, addressing critical needs in pharmaceutical research.
References
- Plumb RS, Lai SK, Gethings LA, Trengove R, Hancock P, Wilson ID. An investigation of the plasma and urinary metabolite profiles of the hepatotoxin methapyrilene in the male Wistar rat. J Pharm Biomed Anal. 2025;264:116976.
- Graichen ME, Neptun DA, Dent JG, Popp JA, Leonard TB. Effects of methapyrilene on rat hepatic xenobiotic enzymes and liver morphology. Fundam Appl Toxicol. 1985;5:165–174.
- Ratra GS, Cottrell C, Powell CJ. Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene. Toxicol Sci. 1998;46:185–196.
- Ratra GS, Powell CJ, Park BK, Maggs JL, Cottrell S. Methapyrilene hepatotoxicity is associated with increased hepatic glutathione, the formation of glucuronide conjugates, and enterohepatic recirculation. Chem Biol Interact. 2000;129:279–295.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.